Clinical presentation, risk factors and staging systems of cholangiocarcinoma

Best Practice and Research: Clinical Gastroenterology

Volumn 29, Issue 2, 2015, Pages 245-252

  Plentz, Ruben R ^a   Malek, Nisar P ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Cholangiocarcinoma; Risks; Staging systems; Symptoms

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

ABDOMINAL PAIN; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT CARCINOMA; BILE DUCT STONE; BILE DUCT TUMOR; BILIRUBIN BLOOD LEVEL; BISMUTH CORLETTE SYSTEM; CANCER RISK; CANCER STAGING; CAROLI DISEASE; CHOLESTASIS; CLINICAL FEATURE; COMMON BILE DUCT STONE; CROHN DISEASE; EXTRAHEPATIC BILE DUCT TUMOUR; FATIGUE; GALLSTONE; HEALTH CARE ORGANIZATION; HUMAN; JAUNDICE; LOSS OF APPETITE; MAYO CLINIC SCORE; NIGHT SWEAT; PRIMARY SCLEROSING CHOLANGITIS; PRURITUS; ULCERATIVE COLITIS; VOMITING; WEIGHT REDUCTION; ASIA; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; INCIDENCE; INTRAHEPATIC BILE DUCT; PATHOLOGY; RISK FACTOR;

ASIA; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; HUMANS; INCIDENCE; RISK FACTORS;

EID: 84929284936     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2015.02.001     Document Type: Review

References (89)

1. M.T. Carriaga, and D.E. Henson Liver, gallbladder, extrahepatic bile ducts, and pancreas Cancer 75 1995 171 190
2. M. Gatto, and D. Alvaro New insights on cholangiocarcinoma World J Gastrointest Oncol 15 2 2010 36 145
3. T.M. Welzel, K.A. McGlynn, A.W. Hsing, T.R. O'Brien, and R.M. Pfeiffer Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States J Natl Cancer Inst 98 2006 873 875
4. Y.H. Shaib, J.A. Davila, K. McGlynn, and H.B. El-Serag Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 40 2004 472 477
5. M.L. DeOliveira, S.C. Cunningham, J.L. Cameron, F. Kamangar, J.M. Winter, and K.D. Lillemoe et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution Ann Surg 245 2007 May 755 762
6. D. Alvaro, M.C. Bragazzi, A. Benedetti, L. Fabris, G. Fava, and P. Invernizzi et al. Cholangiocarcinoma in Italy: a national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease Dig Liver Dis 43 2011 60 65
7. G.L. Tyson, and H.B. El-Serag Risk factors for cholangiocarcinoma Hepatology 54 1 2011 173 184
8. S.A. Khan, B.R. Davidson, R.D. Goldin, N. Heaton, J. Karani, and S.P. Pereira et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update Gut 61 2012 1657 1669
9. K.M. Boberg, and G.E. Lind Primary sclerosing cholangitis and malignancy Best Pract Res Clin Gastroenterol 25 2011 753 764
10. H. Ehlken, and C. Schramm Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics Dig Dis 31 2013 118 125
11. N. Chalasani, A. Baluyut, A. Ismail, A. Zaman, G. Sood, and R. Ghalib et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter study Hepatology 31 2000 7 11
12. A. Bergquist, A. Ekbom, R. Olsson, D. Kornfeldt, L. Lööf, and A. Danielsson et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis J Hepatol 36 2002 321 327
13. K.M. Boberg, A. Bergquist, S. Mitchell, A. Pares, F. Rosina, and U. Broomé et al. Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation Scand J Gastroenterol 37 2002 1205 1211
14. K. Burak, P. Angulo, T.M. Pasha, K. Egan, J. Petz, and K.D. Lindor Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis Am J Gastroenterol 99 2004 523 526
15. M.M. Claessen, F.P. Vleggaar, K.M. Tytgat, P.D. Siersema, and H.R. van Buuren High lifetime risk of cancer in primary sclerosing cholangitis J Hepatol 50 2009 158 164
16. C.B. Rosen, D.M. Nagorney, R.H. Wiesner, R.J. Coffey Jr., and N.F. LaRusso Cholangiocarcinoma complicating primary sclerosing cholangitis Ann Surg 213 1991 21 25
17. R. Erichsen, P. Jepsen, H. Vilstrup, A. Ekbom, and H.T. Sørensen Incidence and prognosis of cholangiocarcinoma in Danish patients with and without inflammatory bowel disease: a national cohort study, 1978-2003 Eur J Epidemiol 24 2009 513 520
18. R. Chapman, J. Fevery, A. Kalloo, D.M. Nagorney, K.M. Boberg, and B. Shneider et al. Diagnosis and management of primary sclerosing cholangitis Hepatology 51 2010 660 678
19. C. Rupp, K. Bode, F. Chahoud, A. Wannhoff, K. Friedrich, and K.H. Weiss et al. Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis BMC Infect Dis 23 14 2014 562 [Epub ahead of print]
20. Y. Shaib, and H.B. El-Serag The epidemiology of cholangiocarcinoma Semin Liver Dis 24 2 2004 115 125
21. K. Okuda, Y. Nakanuma, and M. Miyazaki Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology J Gastroenterol Hepatol 17 2002 1049 1055
22. P. Tabrizian, G. Jibara, B. Shrager, M.E. Schwartz, and S. Roayaie Hepatic resection for primary hepatolithiasis: a single-center Western experience J Am Coll Surg 215 2012 622 626
23. A. Guglielmi, A. Ruzzenente, A. Valdegamberi, F. Bagante, S. Conci, and A.D. Pinna et al. Hepatolithiasis-associated cholangiocarcinoma: results from a multi-institutional national database on a case series of 23 patients EJSO 40 2014 567 575
24. S.M. Sheen-Chen, F.F. Chou, and H.L. Eng Intrahepatic cholangiocarcinoma in epatolithiasis: a frequently overlooked disease J Surg Oncol 47 1991 131 135
25. Y. Zen, M. Sasaki, T. Fujii, T.C. Chen, M.F. Chen, and T.S. Yeh et al. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct e an immunohistochemical study of 110 cases of hepatolithiasis J Hepatol 44 2 2006 350 358
26. T.Y. Lee, S.S. Lee, S.W. Jung, S.H. Jeon, S.C. Yun, and H.C. Oh et al. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study Am J Gastroenterol 103 2008 1716 1720
27. Y.M. Zhou, Z.F. Yin, J.M. Yang, B. Li, W.Y. Shao, and F. Xu et al. Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China World J Gastroenterol 14 2008 632 635
28. M.H. Huang, C.H. Chen, C.M. Yen, J.C. Yang, C.C. Yang, and Y.H. Yeh et al. Relation of hepatolithiasis tohelminthic infestation J Gastroenterol Hepatol 20 2005 141 146
29. Z.Y. Liu, Y.M. Zhou, L.H. Shi, and Z.F. Yin Risk factors of intrahepatic cholangiocarcinoma in patients with hepatolithiasis: a case control study Hepatobiliary Pancreat Dis Int 10 2011 626 631
30. D. Schottenfeld, and J. Beebe-Dimmer Chronic inflammation: a common and important factor in the pathogenesis of neoplasia CA Cancer J Clin 56 2006 69 83
31. T.M. Welzel, L. Mellemkjaer, G. Gloria, L.C. Sakoda, A.W. Hsing, and G.L. El et al. Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study Int J Cancer 120 2007 638 641
32. E.K. Abdalla, C.E. Forsmark, G.Y. Lauwers, and J.N. Vauthey Monolobar Caroli's disease and cholangiocarcinoma HPB Surg 11 1999 271 276 [discussion 276-277]
33. R.W. Chapman Risk factors for biliary tract carcinogenesis Ann Oncol 10 Suppl. 4 1999 308 311
34. V.J. Desmet Congenital diseases of intrahepatic bile ducts: variations on the theme "ductal plate malformation" Hepatology 16 1992 1069 1083
35. W.T. Kassahuhn, T. Kahn, C. Wittekind, J. Mössner, K. Caca, and J. Hauss et al. Caroli's disease: liver resection and liver transplantation. Experience in 33 patients Surgery 138 2005 888 898
36. J.C. Lendorie, G. Raffin, J. Grondona, R. Bracco, R. Russi, and V. Ardiles et al. Caroli's disease: report of surgical options and long-term outcome of patients treated in Argentin. Multicenter study J Gastrointest Surg 15 2011 1814 1819
37. M. Baghbanian, H. Salmanroghani, and A. Baghbanian Cholangiocarcinoma or Caroli disease: a case report Gastroenterol Hepatol 6 2013 214 2016
38. H.U. Kasper, D.L. Stippel, U. Töx, U. Drebber, and H.P. Dienes Primary cholangiocarcinoma in a case of Caroli's disease: a case report and literature review Pathologe 27 2006 300 304
39. K. Soreide, H. Korner, J. Havnen, and J.A. Soreide Bile duct cysts in adults Br J Surg 91 2004 1538 1548
40. B.R. Blechacz, and G.J. Gores Cholangiocarcinoma Clin Liver Dis 12 2008 131 150
41. J.Y. Mabrut, G. Bozio, C. Hubert, and J.F. Gigot Management of congenital bile duct cysts Dig Surg 27 2010 12 18
42. B.H. Edil, J.L. Cameron, S. Reddy, Y. Lum, P.A. Lipsett, and H. Nathan et al. Choledochal cyst disease in children and adults: a 30-year single-institution experience J Am Coll Surg 206 2008 May 1000 1005
43. M. Yamaguchi Congenital choledochal cyst. Analysis of 1,433 patients in the Japanese literature Am J Surg 140 1980 653 657
44. Y. Watanabe, A. Toki, and T. Todani Bile duct cancer developed after cyst excision for choledochal cyst J Hepatobiliary Pancreat Surg 6 1999 207 212
45. C.R. Voyles, C. Smadja, W.C. Shands, and L.H. Blumgart Carcinoma in choledochal cysts. Age-related incidence Arch Surg 118 1983 986 988
46. S. Kobayashi, T. Asano, M. Yamasaki, T. Kenmochi, T. Nakagohri, and T. Ochiai Risk of bile duct carcinogenesis after excision of extrahepatic bile ducts in pancreaticobiliary maljunction Surgery 126 1999 939 944
47. K. Matsumoto, T. Onoyama, S. Kawata, Y. Takeda, K. Harada, and Y. Ikebuchi et al. Hepatitis B and C virus infection is a risk factor for the development of cholangiocarcinoma Intern Med 53 2014 651 654
48. F. Donato, U. Gelatti, A. Tagger, M. Favret, M.L. Ribero, and F. Callea et al. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy Cancer Causes Control 12 2001 959 964
49. T.M. Welzel, B.I. Graubard, H.B. El-Serag, Y.H. Shaib, A.W. Hsing, and J.A. Davila et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study Clin Gastroenterol Hepatol 5 2007 1221 1228
50. G. Raimondo, T. Pollicino, I. Cacciola, and G. Squadrito Occult hepatitis B virus infection J Hepatol 46 2007 160 170
51. N.K. Gatselis, K. Tepetes, A. Loukopoulos, K. Vasiou, A. Zafiriou, and C. Gioti et al. Hepatitis B virus and intrahepatic cholangiocarcinoma Cancer Invest 25 2007 55 58
52. Y.M. Zhou, L. Cao, B. Li, X.Z. Zhang, and Z.F. Yin Expression of HBx protein in hepatitis B virus-infected intrahepatic cholangiocarcinoma Hepatobiliary Pancreat Dis Int 11 2012 532 535
53. Y. Zhou, Q. Zhou, Q. Lin, R. Chen, Y. Gong, and Y. Liu et al. Evaluation of risk factors for extrahepatic cholangiocarcinoma: ABO blood group, hepatitis B virus and their synergism Int J Cancer 133 2013 1867 1875
54. H.B. Zhou, J.Y. Hu, and H.P. Hu Hepatitis B virus infection and intrahepatic cholangioacrcinoma World J Gastroenterol 20 2014 5721 5729
55. Y. Li, H. Wang, D. Li, J. Hu, H. Wang, and D. Zhou et al. OcculthepatitisBvirusinfection in chinese cryptogenic intrahepatic cholangiocarcinomapatientpopulation J Clin Gastroenterol 48 2014 878 882
56. F. Yin, and B. Chen Detection of hepatitis C virus RNA sequences in hepatic portal cholangiocarcinoma tissue by reverse transcription polymerase chain reaction Chin Med J 111 1998 1068 1070
57. L.Y. Tao, X.D. He, Q. Qu, L. Cai, W. Liu, and L. Zhou et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China Liver Int 30 2010 215 221
58. Z.F. Wu, N. Yang, D.Y. Li, H.B. Zhang, and G.S. Yang Characteristics of intrahepatic cholangiocarcinoma in patients with hepatitis B virus infection: clinicopathologic study of resected tumours J Viral Hepat 20 2013 306 310
59. T.T. Wu, M. Levy, A.M. Correa, C.B. Rosen, and S.C. Abraham Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases Cancer 115 2009 4564 4575
60. R.F. Chen, Z.H. Li, S.Q. Zou, and J.S. Chen Effect of hepatitis C virus core protein on modulation of cellular proliferation and apoptosis in hilar cholangiocarcinoma Hepatobiliary Pancreat Dis Int 4 2005 71 74
61. T. Li, D. Li, L. Cheng, H. Wu, Z. Gao, and Z. Liu et al. Epithelialmesenchymal transition induced by hepatitis C virus core protein in cholangiocarcinoma Ann Surg Oncol 17 2010 1937 1944
62. H. Lu, M.Q. Ye, S.N. Thung, S. Dash, and M.A. Gerber Detection of hepatitis C virus RNA sequences in cholangiocarcinomas in Chinese and American patients Chin Med J 113 2000 1138 1141
63. W.L. Wang, G.Y. Gu, and M. Hu Expression and significance of HBV genes and their antigens in human primary intrahepatic cholangiocarcinoma World J Gastroenterol 4 1998 392 396
64. Y.H. Shaib, H.B. El-Serag, A.K. Nooka, M. Thomas, T.D. Brown, and Y.Z. Patt et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study Am J Gastroenterol 102 2007 1016 1021
65. S. Ralphs, and S.A. Khan The role of the hepatitis viruses in cholangiocarcinoma J Viral Hepat 20 2013 297 305
66. P. Watanapa, and W.B. Watanapa Liver fluke-associated cholangiocarcinoma Br J Surg 89 2002 962 970
67. M.R. Haswell-Elkins, S. Satarug, M. Tsuda, E. Mairiang, H. Esumi, and P. Sithithaworn et al. Liver fluke infection and cholangiocarcinoma: model of endogenous nitric oxide and extragastric nitrosation in human carcinogenesis Mutat Res 305 1994 241 252
68. N. Bhamarapravati, W. Thammavit, and S. Vajrasthira Liver changes in hamsters infected with a liver fluke of man, Opisthorchis viverrini Am J Trop Med Hyg 27 1978 787 794
69. D.M. Parkin, P. Srivatanakul, M. Khlat, D. Chenvidhya, P. Chotiwan, and S. Insiripong et al. Liver cancer in Thailand. I. A case-control study of cholangiocarcinoma Int J Cancer 48 1991 323 328
70. D. Choi, J.H. Lim, K.T. Lee, J.K. Lee, S.H. Choi, and J.S. Heo et al. Cholangiocarcinoma and Clonorchis sinensis infection: a casecontrol study in Korea J Hepatol 44 2006 1066 1073
71. M.K. Lim, Y.H. Ju, S. Franceschi, J.K. Oh, H.J. Kong, and S.S. Hwang et al. Clonorchis sinensis infection and increasing risk of cholangiocarcinoma in the Republic of Korea Am J Trop Med Hyg 75 2006 93 96
72. H.R. Shin, C.U. Lee, H.J. Park, S.Y. Seol, J.M. Chung, and H.C. Choi et al. Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea Int J Epidemiol 25 1996 933 940
73. Q. Cheng, X. Luo, B. Zhang, X. Jiang, B. Yi, and M. Wu Predictive factors for prognosis of hilar cholangiocarcinoma: postresection radiotherapy improves survival Eur J Surg Oncol 33 2007 202 207
74. B. Sripa, S. Kaewkes, P. Sithithaworn, E. Mairiang, T. Laha, and M. Smout et al. Liver fluke induces cholangiocarcinoma PLoS Med 4 2007 1148 1155
75. B.J. Vennerwald, and K. Polman Helminths and malignancy Parasite Immunol 31 2009 686 696
76. V. Wiwanitkit Peticides, fresh water fish, liver flukes and nitrosamine: a story of cholangiocarcinoma development in thailand Asian Pac J Cancer Prev 10 2009 939 940
77. I. Kato, and C. Kido Increased risk of death in thorotrast-exposed patients during the late follow-up period Jpn J Cancer Res 78 1987 1187 1192
78. G. Brandi, S. Di Girolamo, A. Farioli, F. de Rosa, S. Curti, and A.D. Pinna et al. Asbestos: a hidden player behind the cholangiocarcinoma increase? Findings from a case control analysis Cancer Causes Control 24 2013 911 918
79. Y.H. Shaib, H.B. El-Serag, J.A. Davila, R. Morgan, and K.A. McGlynn Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study Gastroenterology 128 2005 620 626
80. M.J. Grainge, J. West, M. Solaymani-Dodaran, G.P. Aithal, and T.R. Card The antecedents of biliary cancer: a primary care case-control study in the United Kingdom Br J Cancer 100 2009 178 180
81. H.T. Sorensen, S. Friis, J.H. Olsen, A.M. Thulstrup, L. Mellemkjaer, and M. Linet et al. Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark Hepatology 28 1998 921 925
82. B. Blechacz, M. Komuta, T. Roskams, and G.J. Gores Clinical diagnosis and staging of cholangiocarcinoma Nat Rev Gastroenterol Hepatol 8 2011 512 522
83. H. Bismuth, and D. Castaing Hepatobiliary malignancy 1994 Edward Arnold London 416e24
84. A. Paul, G.M. Kaiser, E.P. Molmenti, T. Schroeder, S. Vernadakis, and A. Oezcelik et al. Am Surg 77 2011 1695 1699
85. L.H. Sobin, M.K. Gospodarowicz, and C. Wittekind TNM classification of malignant tumors 7th ed. 2009 John Wiley & Sons New York, NY
86. M.S. Cho, S.H. Kim, S.W. Park, J.H. Lim, G.H. Choi, and J.S. Park et al. Surgical outcomes and predicting factors of curative resection in patients with hilar cholangiocarcinoma: 10-year single-institution experience J Gastrointest Surg 16 2012 1672 1679
87. W.R. Jarnagin, Y. Fong, R.P. DeMatteo, M. Gonen, E.C. Burke, and B.J. Bodniewicz et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma Ann Surg 234 2001 507 517
88. M.L. Deoliveira, R.D. Schulick, Y. Nimura, C. Rosen, G. Gores, and P. Neuhaus et al. New staging system and a registry for perihilar cholangiocarcinoma Hepatology 53 2011 1363 1371
89. R. Chaiteerakij, W.S. Harmsen, C.R. Marrero, M.M. Aboelsoud, A. Ndzengue, and J. Kaiya et al. A new clinically based staging system for perihilar cholangiocarcinoma Am J Gastroenterol 109 2014 1881 1890